509707 Sigma-Aldrich(S)-5-Iodowillardiine - CAS 140187-25-3 - Calbiochem
A potent and selective agonist for GluK1-containing kainate receptors (EC₅₀ = 0.06 and 0.21 µM for GluK1/K5 and GluK1, respectively). Does not interact with GluK2, GluK6, and GluK7 receptors.
More>> A potent and selective agonist for GluK1-containing kainate receptors (EC₅₀ = 0.06 and 0.21 µM for GluK1/K5 and GluK1, respectively). Does not interact with GluK2, GluK6, and GluK7 receptors. Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Synonyms: (S)-α-Amino-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinepropanoic acid, (S)-2-amino-3-(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoic acid, Iodowillardiine
Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
Empirical Formula |
---|
C₇H₈IN₃O₄ |
Pricing & Availability
Catalog Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
5.09707.0001 |
|
Glass bottle | 10 mg |
|
— |
Product Information | |
---|---|
CAS number | 140187-25-3 |
Form | White solid |
Hill Formula | C₇H₈IN₃O₄ |
Chemical formula | C₇H₈IN₃O₄ |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | GluK1 |
Purity | ≥98% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Documentation
(S)-5-Iodowillardiine - CAS 140187-25-3 - Calbiochem SDS
Title |
---|
References
Reference overview |
---|
Bhangoo, K., et al. 2013. Mol. Pharmacol. 83, 307. Moldrich, X., et al. 2000. J. Neurosci. Res. 59, 788. Chittajallu, R., et al. 1999. Trends Pharmacol. Sci. 20, 26. Swanson, T., et al. 1998. Mol. Pharmacol. 53, 942. |